Research & Development

Continues Vigorous Development

Including the Pharmaceutical Delivery System (PDS) device and replacement cartridges, as well as liquid formulations for a number of markets and other purposes, including but not limited to the tobacco and nicotine market -including reduced risk products and nicotine replacement therapy - for medical and personal use.

bionebicine science image

Engineering - patent pending

Our engineering team has recently completed version 2.0 of the PDS. It is a single dose system which includes many new and exciting features:
  • A Vial cage that holds the medication vial in place
  • Increased flow rates that can now be changed as warranted by specific patients’ needs and for different medications
  • The ability to lock out a vial after a dose has been administered
  • Version 3.0 is ongoing and will include bluetooth communication with a smartphone, fingerprint ID and other exciting features

Endotracheal Tube

  • Bionebicine’s CEO, Dr. Donald Pell, developed a non-kinking endotracheal tube and applied for a US patent in 2009.
  • The USPTO approved and published a patent for Dr. Pell’s endotracheal tube in 2012.
  • Bionebicine acquired the patent in 2019
  • There are currently no FDA standards for endotracheal tubes, which has created a market of tubes that kink after they are inserted into patients
  • These tubes kink because they are not Silicone reinforced and they kink when inside of a 100 degree human body
  • An endotracheal tube that has been used to intubate a patient can result in accidental death if it kinks
  • Bionebicine’s tube is made of Silicone, which does not kink when inserted into a 100 degree human body
  • Bionebicine’s tube has a distinctly different type of balloon, which is covered by our approved patent, that prevents gastric contents from clogging the tube

Sounds

Dr. Pell also developed an apparatus called "Sounds”, which is a small diameter ball on a flexible shaft. When the Sound is inserted into an endotracheal tube (which is in an intubated patient) it will determine if the tube is kinked. Bionebicine has a patent pending on the Sound apparatus, and anticipates that approval is imminent.